Experience with the wearable cardioverter-defibrillator in patients at high risk for sudden cardiac death

Circulation

Volumn 134, Issue 9, 2016, Pages 635-643

  Wäßnig, Nadine K ^a   Günther, Michael ^a   Quick, Silvio ^a   Pfluecke, Christian ^a   Rottstädt, Fabian ^a   Szymkiewicz, Steven J ^b   Ringquist, Steven ^b   Strasser, Ruth H ^a   Speiser, Uwe ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b ZOLL Medical Corporation   (United States)

Author keywords

arrhythmias, cardiac; death, sudden, cardiac; electric countershock; heart failure; myocarditis

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFACT; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONGESTIVE CARDIOMYOPATHY; EXTERNAL DEFIBRILLATOR; FEMALE; FOLLOW UP; GERMANIC PEOPLE; HEART ARREST; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INAPPROPRIATE SHOCK; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; NONISCHEMIC CARDIOMYOPATHY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUDDEN CARDIAC DEATH; SUPRAVENTRICULAR TACHYCARDIA; SURVIVAL; TREATMENT RESPONSE; WEARABLE CARDIOVERTER DEFIBRILLATOR; CLINICAL TRIAL; DEATH, SUDDEN, CARDIAC; DEFIBRILLATOR; MIDDLE AGED; MULTICENTER STUDY; RISK FACTOR; VENTRICULAR FIBRILLATION;

AGED; COHORT STUDIES; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; VENTRICULAR FIBRILLATION;

EID: 84979995609     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.115.019124     Document Type: Article

References (21)

1. Feldman AM, Klein H, Tchou P, Murali S, Hall WJ, Mancini D, Boehmer J, Harvey M, Heilman MS, Szymkiewicz SJ, Moss AJ, WEARIT Investigators and Coordinators; BIROAD Investigators and Coordinators Use of a wearable defibrillator in terminating tachyarrhythmias in patients at high risk for sudden death: results of the WEARIT/BIROAD. Pacing Clin Electrophysiol 2004 27 4 9
2. Reek S, Geller JC, Meltendorf U, Wollbrueck A, Szymkiewicz SJ, Klein HU, Clinical efficacy of a wearable defibrillator in acutely terminating episodes of ventricular fibrillation using biphasic shocks. Pacing Clin Electrophysiol 2003 26 2016 2022
3. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M, Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia: Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996 335 1933 1940. doi: 10.1056/NEJM199612263352601
4. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML, Multicenter Automatic Defibrillator Implantation Trial II Investigators Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002 346 877 883. doi: 10.1056/NEJMoa013474
5. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH, Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005 352 225 237. doi: 10.1056/NEJMoa043399
6. Teeter WA, Thibodeau JT, Rao K, Brickner ME, Toto KH, Nelson LL, Mishkin JD, Ayers CR, Miller JG, Mammen PP, Patel PC, Markham DW, Drazner MH, The natural history of new-onset heart failure with a severely depressed left ventricular ejection fraction: implications for timing of implantable cardioverter-defibrillator implantation. Am Heart J 2012 164 358 364. doi: 10.1016/j.ahj.2012.06.009
7. Binkley PF, Lesinski A, Ferguson JP, Hatton PS, Yamokoski L, Hardikar S, Cooke GE, Leier CV, Recovery of normal ventricular function in patients with dilated cardiomyopathy: predictors of an increasingly prevalent clinical event. Am Heart J 2008 155 69 74. doi: 10.1016/j.ahj.2007.08.010
8. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Faxon DP, Halperin JL, Hiratzka LF, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura RA, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CW, Americann College of Cardiology/Americann Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices); Americann Association for Thoracic Surgery; Society of Thoracic Surgeons ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the Americann College of Cardiology/Americann Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the Americann Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008 117 e350 e408. doi: 10.1161/CIRCUALTIONAHA.108.189742
9. Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, Fain E, Gent M, Connolly SJ, DINAMIT Investigators Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 2004 351 2481 2488. doi: 10.1056/NEJMoa041489
10. Zishiri ET, Williams S, Cronin EM, Blackstone EH, Ellis SG, Roselli EE, Smedira NG, Gillinov AM, Glad JA, Tchou PJ, Szymkiewicz SJ, Chung MK, Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillator. Circ Arrhythm Electrophysiol 2013 6 117 128. doi: 10.1161/CIRCEP.112.973552
11. Klein HU, Goldenberg I, Moss AJ, Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator. Eur Heart J 2013 34 2230 2242. doi: 10.1093/eurheartj/eht167
12. Bobrow BJ, Spaite DW, Berg RA, Stolz U, Sanders AB, Kern KB, Vadeboncoeur TF, Clark LL, Gallagher JV, Stapczynski JS, LoVecchio F, Mullins TJ, Humble WO, Ewy GA, Chest compression-only CPR by lay rescuers and survival from out-of-hospital cardiac arrest. JAMA 2010 304 1447 1454. doi: 10.1001/jama.2010.1392
13. R Core Team. R: A Language and Environment for Statistical Computing 2014 Vienna, Austria R Foundation for Statistical Computing. http://www.R-project.org/. Accessed July 27, 2016
14. Chongsuvivatwong V, epicalc: epidemiological calculator. R package version 2.15.1.0. 2012. http://CRAN.R-project.org/package=epicalc. Accessed July 27, 2016
15. Chung MK, Szymkiewicz SJ, Shao M, Zishiri E, Niebauer MJ, Lindsay BD, Tchou PJ, Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival. J Am Coll Cardiol 2010 56 194 203. doi: 10.1016/j.jacc.2010.04.016
16. Epstein AE, Abraham WT, Bianco NR, Kern KB, Mirro M, Rao SV, Rhee EK, Solomon SD, Szymkiewicz SJ, Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction. J Am Coll Cardiol 2013 62 2000 2007. doi: 10.1016/j.jacc.2013.05.086
17. Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, Estes NA 3rd, Greenberg H, Hall WJ, Huang DT, Kautzner J, Klein H, McNitt S, Olshansky B, Shoda M, Wilber D, Zareba W, MADIT-RIT Trial Investigators Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med 2012 367 2275 2283. doi: 10.1056/NEJMoa1211107
18. Klein RC, Raitt MH, Wilkoff BL, Beckman KJ, Coromilas J, Wyse DG, Friedman PL, Martins JB, Epstein AE, Hallstrom AP, Ledingham RB, Belco KM, Greene HL, AVID Investigators Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. J Cardiovasc Electrophysiol 2003 14 940 948
19. Kutyifa V, Moss AJ, Klein H, Biton Y, McNitt S, MacKecknie B, Zareba W, Goldenberg I, Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry). Circulation 2015 132 1613 1619. doi: 10.1161/CIRCULATIONAHA.115.015677
20. Schwab JO, Bänsch D, Israel C, Nowak B, Opinion on the use of the portable cardioverter/defibrillator. Der Kardiologe 2015 9 165 170
21. Priori SG, Blomström-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, Elliott PM, Fitzsimons D, Hatala R, Hindricks G, Kirchhof P, Kjeldsen K, Kuck KH, Hernandez-Madrid A, Nikolaou N, Norekvål TM, Spaulding C, Van Veldhuisen DJ, Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Europace 2015 17 1601 1687. doi: 10.1093/europace/euv319